Data from a large prospective study identified male and older patients as being more likely to develop CIP and 34% of cases ...
Long-term NATALEE data show adjuvant ribociclib plus an aromatase inhibitor improves invasive disease–free survival vs AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback